MTOR

Digital mental health (DMH) interventions for PTSD address well-documented barriers to traditional in-person psychotherapy or telehealth delivery of evidence-based treatments (EBTs) for PTSD, but many consumers do not remain engaged. Thus, acceptable, efficient, and engaging forms of EBTs are sorely needed.

The overarching objective of this project is to rigorously assess how state-level COVID-19 mitigation policies have affected psychological health and related mortality from drug overdose and suicide among working age and older adults.

COVID-19 has led to disruptions and delays in routine pediatric care, including for children with diabetes. Routine pediatric visits have been reduced or transitioned to telemedicine due to COVID- 19, creating barriers for those without technology and internet capabilities.

The pandemic has disrupted care transitions from hospitals to home healthcare agencies and nursing homes, which may lead to important health outcomes consequences, including the widening of existing health disparities.

This project uses a randomized controlled trial of a novel mobile peer support app platform among a national sample of 1300 patients in recovery from opioid use disorders (OUDs), as an adjunct to usual care, during COVID-19.

Based on the injury risk-reduction program Vales+Tu (You Are Worth More) that has been successfully tested among Latino Day Laborers, the Vale+Tu Salud (Your Health is Worth More) study will adapt its evidence-based strategies to promote group problem solving and a plan to implement together COVID-19 mitigation strategies

The objective of this study is to determine whether community service use for those with social needs improves general and COVID-related health outcomes, and whether random assignment to intensive follow-up and collaborative goal setting helps overcome barriers to community service use.

This administrative supplement continues a high-frequency longitudinal survey of Americans’ experiences and behavior during the COVID-19 pandemic to measure perceptions of coronavirus risk, individual prevention behaviors, consumption of coronavirus information from various sources, effects on households' financial situations and physical and mental health, and coping behavior of households.

Woebot for Substance Use Disorders (W-SUDs) is a two-phase NIDA-funded SBIR. Presently, W-SUDs, a novel digital therapeutic, is being evaluated in the Phase I pilot. Phase II will investigate W-SUDs’s efficacy compared to an active control condition.